Double trouble: are lupus and malignancy associated?

Abstract

Get full access to this article

View all access options for this article.

References

Shoenfeld Y , Gershwin ME . Cancer and Autoimmunity. Elsevier Science: Oxford , 2000.

Villa AR , Kraus A , Jimenez-Corona A , Sandino S , Grandados AV-G Jr et al. Malignant neoplasms in autoimmune rheumatic diseases. Examination of the risk of developing a malignancy among five different rheumatic diseases in one institution . J Clin Rheumatol 2000; 6: 176-183 .

Villa AR , Kraus A , Alarcon-Segovia A . Autoimmune rheumatic diseases and cancer: evidence or causality? In: Shoenfeld Y , Gershwin ME (eds). Cancer and Autoimmunity: Elsevier Science: Oxford , 2000, pp 111-117.

Bradford-Hill A . The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300 .

Sigureirsson B , Lindelof B , Edhag O , Allander E . Risk of cancer in patients with dermatomyositis or polymyositis. A population based study . New Engl J Med 1992; 326: 363-367 .

Hill CL , Zhang Y , Sigurgeirsson B et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study . Lancet 2001; 357: 96-100 .

McCurley TE , Collins RD , Ball E . Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathological study . Hum Pathol 1990; 21: 482-492 .

Roumm AD , Medsger TA Jr. Cancer and systemic sclerosis, an epidemiologic study . Arthritis Rheum 1985; 28: 1336-1340 .

Gridley G , Klippel JH , Hoover RN , Fraumeni JFJ . Incidence of cancer among men with the Felty's syndrome . Ann Int Med 1994; 120: 35-39 .

10.

Cibere J , Sibley J , Haga M . Systemic lupus erythematosus and the risk of malignancy . Lupus 2001; 10 394-400 .

11.

Pettersson T , Pukkala E , Teppo L , Friman C . Increased risk of cancer in patients with systemic lupus erythematosus . Ann Rheum Dis 1992; 51: 437-439 .

12.

Mellemkjaer L , Andersen V , Linet MS , Gridley G , Hoover R , Olsen JH . Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 761-768 .

13.

Asherson RA , Block S , Houssian FA , Hughes GRV . Systemic lupus erythematosus and lymphoma: association with an antiphospholipid syndrome . J Rheumatol 1991; 18: 277-279 .

14.

Green JA , Dawson AA , Walker W . Systemic lupus erythematosus and lymphoma . Lancet 1978; ii: 753-756 .

15.

Agudelo CA , Schumacher HR , Glick JH , Molina J . Non-Hodgkin's lymphoma in systemic lupus erythematosus. Report of 4 cases with ultrastructural studies in 2 . J Rheumatol 1981; 8: 69-78 .

16.

Cammarata RJ , Rodnan GP , Jensen WN . Systemic rheumatic diseases and malignant lymphoma . Arch Intern Med 1963; 111: 330-337 .

17.

Abu-Shakra M , Gladman DD , Urowitz MB . Malignancy in systemic lupus erythematosus . Arthritis Rheum 1996; 39: 1050-1054 .

18.

Posner MA , Gloster ES , Bonagura VR , Valocer DJ , Ilowite NT . Burkitt's lymphoma in a patient with systemic lupus erythematosus . J Rheumatol 1990; 17: 380-382 .

19.

Lishner M , Hawker G , Amato D . Chronic lymphocytic leukemia in a patient with systemic lupus erythematosus . Acta Haematol 1990; 84: 38-39 .

20.

Stahl-Hallengren C , Jonsen A , Nived O , Sturfelt G . Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis . J Rheumatol 2000; 27: 685-691 .

21.

Sultan SM , Ioannou Y , Isenberg DA . Is there an association of malignancy with SLE? An analysis of 276 patients under longterm review . Rheumatol 2000; 39: 1147-1152 .

22.

Canoso JJ , Cohen AS . Malignancy in a series of 70 patients with systemic lupus erythematosus . Arthritis Rheum 1974; 17: 383-390 .

23.

Lewis RB , Castor CW , Knisley RE , Bole GG . Frequency of neoplasia in systemic lupus and rheumatoid arthritis . Arthritis Rheum 1976; 19: 1256-1260 .

24.

Nyberg G , Eriksson O , Westberg NG . Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy . Arthritis Rheum 1981; 24: 648-650 .

25.

Blumenfeld Z , Lorber M , Yoffe N , Scharf Y . SLE: predisposition for uterine cervical dysplasia . Lupus 1994; 3: 59-61 .

26.

Bateman H , Yazici Y , Peterson M , Paget SA . Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study . Lupus 2000; 9: 542-544 .

27.

Ramsey-Goldman R , Mattai SA , Schilling E et al. Increased risk of malignancy in patients with systemic lupus erythematosus . J Invest Med 1998; 46: 217-222 .

28.

Ortiz AM , Gonzalez-Parra E , Alvarez-Costa G , Egido J . Bladder cancer after cyclophosphamide therapy for lupus nephritis . Nephron 1992; 60: 378-379 .

29.

Cras P , Franckx C , Martin J . Primary intracerebral lymphoma in systemic lupus erythematosus treated with immunosuppressives . Clin Neuropathol 1989; 8: 200-205 .

30.

Gibbons RB , Westerman E . Acute nonlymphycytic leukemia following short-term intermittent, intravenous cyclophosphamide treatment of lupus nephritis . Arthritis Rheum 1988; 31: 1552-1554 .

31.

Black KA , Zilko PJ , Dawkins RL , Armstrong BK , Mastaglia GL . Cancer in connective tissue disease . Arthritis Rheum 1982; 25: 1130-1133 .

32.

Dupla ML , Khamashta M , Garcia VP , Uriol PL , Ortega EV , Aguado AG . Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients . Lupus 1993; 2: 177-181 .

33.

Menon S , Snaith ML , Isenberg DA . The association of malignancy with SLE: an analysis of 150 patients under long-term review . Lupus 1993; 2: 177-181 .

34.

Sulkes A , Naparstek Y . The infrequent association of systemic lupus erythemaotsus and solid tumors . Cancer 1991; 68: 1389-1393 .

35.

Sweeney DM , Manzi S , Janosky J et al. Risk of malignancy in female patients with systemic lupus erythematosus . J Rheumatol 1995; 22: 1478-1482 .

36.

Nashi E , Clarke A , Joseph L , Fortin P . The incidence of cancer in patients with systemic lupus erythematosus . Arthritis Rheum 2000; 43(Suppl): S165-S165 (abstract).

37.

Leibowitz S , Schwartz RS . Malignancy as complication of immunosuppressive therapy . Adv Intern Med 1971; 17: 95-123 .

38.

Paolozzi FR , Goldberg J . Acute granulocytic leukemia following systemic lupus erythematosus . Am J Med 1985; 290: 32-35 .

39.

Hehir ME , Sewell JR , Hughes GRV . Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus . Ann Rheum Dis 1979; 38: 94-95 .

40.

Butler RC , Thomas SM , Thompson JM , Keat ACS . Anaplastic myeloma in systemic lupus erythematosus . Ann Rheum Dis 1984; 43: 653-655 .

41.

Elliott RW , Essenhigh DM , Morley AR . Cyclophosphamide treatment of systemic lupus erythematous: risk of bladder cancer exceeds benefits . Br Med J 1982; 284: 1160-1161 .

42.

Thrasher JB , Miller GJ , Wettlaufer JN . Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis . J Urol 1990; 143: 119-121 .

43.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of SLE . Arthritis Rheum 1982; 25: 1271-1277 .

44.

Hochberg M . Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

45.

Desai MM , Bruce ML , Desai RA , Druss BG . Validity of self-reported cancer history: A comparison of health interview data and cancer registry records . Am J Epidemiol 2001; 153: 299-306 .